๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The treatment of restless legs syndrome

โœ Scribed by P. Montagna

Publisher
Springer Milan
Year
2007
Tongue
English
Weight
52 KB
Volume
28
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A randomized, double-blind, placebo cont
A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome
โœ Ludger Grote; Lena Leissner; Jan Hedner; Jan Ulfberg ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 228 KB ๐Ÿ‘ 1 views

## Abstract Iron deficiency may exacerbate symptoms in the Restless Legs Syndrome (RLS). We investigated the effect of intravenous iron sucrose or placebo on symptoms in patients with RLS and mild to moderate iron deficit. Sixty patients with primary RLS (seven males, age 46 (9) years, Sโ€ferritin โ‰ค

Ropinirole is effective in the treatment
Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled study
โœ Arthur S. Walters; William G. Ondo; Tilman Dreykluft; Ron Grunstein; Daniel Lee; ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 181 KB ๐Ÿ‘ 1 views

## Abstract Restless legs syndrome (RLS) is a neurological condition with significant impact on sleep and quality of life (QoL). This doubleโ€blind, randomized, 12โ€week, multinational study compared the efficacy and safety of ropinirole and placebo in RLS. In total, 267 outpatients with moderateโ€toโ€

Treatment of restless legs syndrome with
Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine
โœ Frithjof Tergau; Stephan Wischer; Christian Wolf; Walter Paulus ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 293 KB

## Abstract An open pilot study with the dopamine agonist ฮฑโ€dihydroergocryptine (DHEC) was conducted in 16 patients with idiopathic restless legs syndrome (RLS) over a period of 5 weeks. Following a drugโ€free interval of 1 week, the patients were treated with daily doses of 10 to 40 mg DHEC. As com